Latest Insider Transactions at Sea Spine Holdings Corp (SPNE)
This section provides a real-time view of insider transactions for Sea Spine Holdings Corp (SPNE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SeaSpine Holdings Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SeaSpine Holdings Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2022
|
Renee Gaeta Director |
SELL
Open market or private sale
|
Direct |
2,000
-8.29%
|
$24,000
$12.06 P/Share
|
|
Jan 28
2022
|
Keith Valentine Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,798
-4.06%
|
$151,778
$11.39 P/Share
|
|
Jan 28
2022
|
Keith Valentine Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,196
+7.15%
|
-
|
|
Jan 28
2022
|
John J. Bostjancic Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,628
-3.49%
|
$39,908
$11.39 P/Share
|
|
Jan 28
2022
|
John J. Bostjancic Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,919
+6.24%
|
-
|
|
Jan 28
2022
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Payment of exercise price or tax liability
|
Direct |
3,067
-6.52%
|
$33,737
$11.39 P/Share
|
|
Jan 28
2022
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Exercise of conversion of derivative security
|
Direct |
5,901
+11.15%
|
-
|
|
Jan 28
2022
|
Patrick L Keran SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,113
-3.04%
|
$23,243
$11.39 P/Share
|
|
Jan 28
2022
|
Patrick L Keran SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,082
+5.54%
|
-
|
|
Jan 28
2022
|
Tyler Lipschultz SVP, Orthobiologics and BD |
SELL
Payment of exercise price or tax liability
|
Direct |
2,243
-1.78%
|
$24,673
$11.39 P/Share
|
|
Jan 28
2022
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Exercise of conversion of derivative security
|
Direct |
6,484
+4.89%
|
-
|
|
Jan 28
2022
|
John J. Winge Vice President, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
2,235
-2.51%
|
$24,585
$11.39 P/Share
|
|
Jan 28
2022
|
John J. Winge Vice President, Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
7,216
+7.5%
|
-
|
|
Jan 27
2022
|
Beau Standish President, Enabling Tech |
BUY
Conversion of derivative security
|
Direct |
50,000
+50.0%
|
-
|
|
Jan 10
2022
|
Renee Gaeta Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.66%
|
$24,000
$12.35 P/Share
|
|
Jan 01
2022
|
John J. Bostjancic Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,440
-6.23%
|
$83,720
$13.62 P/Share
|
|
Jan 01
2022
|
John J. Bostjancic Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,921
+5.15%
|
-
|
|
Jan 01
2022
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Payment of exercise price or tax liability
|
Direct |
5,183
-11.19%
|
$67,379
$13.62 P/Share
|
|
Jan 01
2022
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Exercise of conversion of derivative security
|
Direct |
8,774
+9.03%
|
-
|
|
Jan 01
2022
|
Patrick L Keran SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,121
-7.25%
|
$66,573
$13.62 P/Share
|
|
Jan 01
2022
|
Patrick L Keran SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,655
+5.94%
|
-
|
|
Jan 01
2022
|
Tyler Lipschultz SVP, Orthobiologics and BD |
SELL
Payment of exercise price or tax liability
|
Direct |
4,801
-3.86%
|
$62,413
$13.62 P/Share
|
|
Jan 01
2022
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Exercise of conversion of derivative security
|
Direct |
11,926
+4.64%
|
-
|
|
Jan 01
2022
|
Keith Valentine Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,167
-3.43%
|
$145,171
$13.62 P/Share
|
|
Jan 01
2022
|
Keith Valentine Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,972
+3.02%
|
-
|
|
Jan 01
2022
|
John J. Winge Vice President, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
4,083
-4.75%
|
$53,079
$13.62 P/Share
|
|
Jan 01
2022
|
John J. Winge Vice President, Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
7,980
+4.53%
|
-
|
|
Dec 31
2021
|
Keith Valentine Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
1,026
+0.34%
|
$8,208
$8.92 P/Share
|
|
Dec 31
2021
|
John J. Winge Vice President, Sales |
BUY
Other acquisition or disposition
|
Direct |
521
+0.66%
|
$5,731
$11.58 P/Share
|
|
Dec 14
2021
|
Angela Steinway Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,782
+50.0%
|
-
|
|
Dec 02
2021
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.05%
|
$481
$13.38 P/Share
|
|
Sep 02
2021
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.05%
|
$592
$16.95 P/Share
|
|
Aug 20
2021
|
Michael Fekete Director |
BUY
Open market or private purchase
|
Direct |
10,000
+10.17%
|
$140,000
$14.8 P/Share
|
|
Jul 21
2021
|
Beau Standish President, Enabling Tech |
SELL
Open market or private sale
|
Direct |
10,100
-100.0%
|
$191,900
$19.24 P/Share
|
|
Jul 16
2021
|
Beau Standish President, Enabling Tech |
SELL
Open market or private sale
|
Direct |
8,054
-44.36%
|
$153,026
$19.24 P/Share
|
|
Jul 15
2021
|
Beau Standish President, Enabling Tech |
SELL
Open market or private sale
|
Direct |
18,154
-50.0%
|
$326,772
$18.83 P/Share
|
|
Jul 02
2021
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Payment of exercise price or tax liability
|
Direct |
4,567
-10.84%
|
$91,340
$20.23 P/Share
|
|
Jul 02
2021
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Exercise of conversion of derivative security
|
Direct |
13,207
+23.87%
|
-
|
|
Jun 30
2021
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
36
-0.05%
|
$720
$20.51 P/Share
|
|
Jun 30
2021
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
792
+1.07%
|
-
|
|
Jun 30
2021
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,097
+0.25%
|
-
|
|
Jun 30
2021
|
Renee Gaeta Director |
BUY
Grant, award, or other acquisition
|
Direct |
609
+2.28%
|
-
|
|
Jun 30
2021
|
Kirtley C. Stephenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
914
+0.85%
|
-
|
|
Jun 30
2021
|
Keith Valentine Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
1,356
+0.44%
|
$10,848
$8.92 P/Share
|
|
Jun 30
2021
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Other acquisition or disposition
|
Direct |
2,383
+2.07%
|
$19,064
$8.92 P/Share
|
|
Jun 30
2021
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Other acquisition or disposition
|
Direct |
2,383
+7.62%
|
$19,064
$8.92 P/Share
|
|
Jun 03
2021
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
382
-0.53%
|
$7,640
$20.28 P/Share
|
|
Jun 02
2021
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,504
+6.27%
|
-
|
|
Jun 02
2021
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,253
+1.39%
|
-
|
|
Jun 02
2021
|
Michael Fekete Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,254
+5.67%
|
-
|